glp 1 and gut microbiome Crosstalk between glucagon-like peptide microbiota in metabolic diseases GLP-1 and Gut Health: Addressing

(20) Baseline measurements of total, pelvic, and arm-leg BMC, CTX-1 and Procollagen Type I N-terminal propeptide (P1NP) were obtained before participants were assigned to the study or control group

These medications require a prescription and professional supervision, as potential side effects might include nausea, diarrhea, constipation, or abdominal discomfort

NASH, Nonalcoholic steatohepatitis

In addition, GLP-1RAs are valuable in the treatment and prevention of diseases of the nervous and cardiovascular system, endocrine disorders, or metabolic diseases due to their neuroprotective, cardiovascular protective, and metabolic regulatory effects

In bariatric surgery, an association of depression with peripheral inflammation was observed regardless of obesity ( The new challenge of GLP-1 RA use reinforces that only an integrative approach is justified in treating each individual patient

Polyphenols in red orange extract support beneficial gut bacteria, which may enhance GLP-1 release naturally